Teva Pharmaceutical Industries Ltd
TEVA
View Detailed Chart
20.460USD
-0.060-0.29%
Close 11/04, 16:00（ET）Quotes delayed by 15 min
23.47BMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-0.29%
5 Days
+3.44%
1 Month
+2.25%
6 Months
+26.37%
Year to Date
-7.17%
1 Year
+9.76%
View Detailed Chart
TradingKey Stock Score of Teva Pharmaceutical Industries Ltd
Currency: USD Updated: 2025-11-04Key Insights
The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Teva Pharmaceutical Industries Ltd's Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
11
analysts
Buy
Current Rating
24.376
Target Price
+18.79%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Teva Pharmaceutical Industries Ltd Highlights
StrengthsRisks
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Undervalued
The company’s latest PE is -145.38, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 734.66M shares, decreasing 10.19% quarter-over-quarter.
Held by Larry Robbins
Star Investor Larry Robbins holds 15.82M shares of this stock.
Teva Pharmaceutical Industries Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Teva Pharmaceutical Industries Ltd Info
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Ticker SymbolTEVA
CompanyTeva Pharmaceutical Industries Ltd
CEOMr. Richard D. Francis
Websitehttps://www.tevapharm.com/
Related Instruments
+1.15%
+0.32%
+1.85%
+0.38%
+0.93%
+1.66%
-1.75%
+0.13%
+0.78%
-1.46%
-1.88%
-1.02%
+2.61%
+1.01%
-0.93%
-0.64%
0.00%
-2.22%
-2.44%
-13.78%Popular Symbols
